動物保健市場分析及預測（至2035年）：類型、產品類型、服務、技術、應用、最終用戶、設備、流程、解決方案

預計動物保健市場規模將從2024年的585億美元成長到2034年的912億美元，年複合成長率約為5.1%。動物保健市場涵蓋旨在改善動物健康和福利的產品和服務，例如藥品、疫苗、診斷試劑和飼料添加劑。該行業涵蓋伴侶動物和牲畜，重點關注疾病的預防、治療和管理。寵物飼養量的成長、畜牧業生產的擴張以及獸醫技術的進步是推動該市場發展的關鍵因素，這些因素促進了生物製藥和數位健康解決方案的創新，從而改善動物的護理和生產力。

動物保健市場正經歷強勁成長，主要得益於動物醫藥和診斷技術的進步。製藥領域是市場的主要驅動力，其中驅蟲藥和抗感染劑憑藉寵物飼養率的提高和人們對牲畜健康意識的增強，成為領先的細分市場。疫苗緊隨其後，主要得益於動物預防性用藥需求的成長。診斷領域發展勢頭強勁，分子診斷和免疫診斷是表現第二好的細分市場。這些技術提高了疾病檢測的準確性，並有助於改善治療效果。尤其值得一提的是，對伴侶動物診斷的需求正在上升，這反映了人類與寵物之間日益加深的關聯。飼料添加劑領域，特別是營養補充品和生長促進劑領域，也不斷擴張。這一成長的驅動力是提高動物生產力和健康水平的需求。此外，數位化動物保健解決方案的創新也為市場提供了支持，這些解決方案簡化了獸醫實踐，提高了動物護理的效率。

動物用藥品市場呈現市場佔有率多元化的特點，成熟企業和新興企業都在不斷推出創新解決方案。定價策略反映了高級產品與經濟實惠替代方案之間的平衡，以滿足不同消費者的需求。近期產品推出凸顯了藥物和診斷工具的進步，強調了療效的提升和使用者便利性的增強。這種充滿活力的市場環境受到預防醫學需求成長和寵物飼養趨勢日益成長的影響。競爭基準分析顯示，市場主要由少數主要企業主導，而新參與企業則透過提供利基產品來擴大市場佔有率。監管影響至關重要，北美和歐洲等地區對市場運作制定了嚴格的指導方針。亞太地區由於有利的法規結構和日益增強的動物健康意識，展現出巨大的發展潛力。市場分析預測，在技術整合和獸醫服務投資增加的推動下，市場將維持強勁的複合年成長率。儘管監管合規和市場飽和等挑戰依然存在，但生物製藥和數位健康解決方案的創新提供了巨大的成長機會。

主要趨勢和促進因素：

受寵物主人數量不斷成長和動物福利意識提升的推動，獸醫保健市場正經歷強勁成長。主要趨勢包括對預防性保健和寵物健康產品的需求不斷成長，這反映出動物照護正朝著預防為主的方向轉變。獸醫診斷技術和治療方法的進步使得疾病的早期發現和有效治療成為可能，從而改善了動物的整體健康。另一個關鍵促進因素是對畜產品需求的成長，這反過來又需要改善畜牧管理實踐和疾病控制。遠端醫療和穿戴式裝置等數位技術的應用正在透過實現即時監測和遠距會診，徹底改變動物保健產業。這些創新對農村和醫療服務不足的地區尤其有益。此外，旨在確保食品安全和防治通用感染疾病的監管支持和政府主導的措施也在推動市場成長。新興市場畜牧業的快速發展蘊藏著許多機會。能夠提供經濟高效且創新解決方案的公司將佔據有利地位，充分利用這些趨勢，確保獸醫保健行業的永續成長。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

• 宏觀經濟分析
• 市場趨勢
• 市場促進因素
• 市場機遇
• 市場限制
• 複合年均成長率：成長分析
• 影響分析
• 新興市場
• 技術藍圖
• 戰略框架

第4章 細分市場分析

• 市場規模及預測：依類型
  • 製藥
  • 生物製藥
  • 飼料添加劑
  • 疫苗
  • 診斷試劑
• 市場規模及預測：依產品分類
  • 抗感染藥物
  • 驅蟲藥
  • 抗發炎藥
  • 藥品和飼料添加劑
  • 營養飼料添加劑
• 市場規模及預測：依服務分類
  • 獸醫診所
  • 移動獸醫服務
  • 遠端醫療
  • 動物康復
• 市場規模及預測：依技術分類
  • 分子診斷
  • 免疫診斷試劑
  • 臨床生物化學
• 市場規模及預測：依應用領域分類
  • 伴侶動物
  • 家畜
  • 水產養殖
  • 鳥類
• 市場規模及預測：依最終用戶分類
  • 獸醫診所
  • 畜牧場
  • 研究所
• 市場規模及預測：依設備分類
  • 手術器械
  • 影像設備
  • 監測設備
• 市場規模及預測：依製程分類
  • 藥物研發
  • 疫苗生產
  • 飼料生產
• 市場規模及預測：按解決方案分類
  • 疾病管理
  • 集團管理

第5章 區域分析

• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲地區
• 亞太地區
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲
  • 台灣
  • 亞太其他地區
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 義大利
  • 其他歐洲地區
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非
  • 撒哈拉以南非洲
  • 其他中東和非洲地區

第6章 市場策略

• 需求與供給差距分析
• 貿易和物流限制
• 價格、成本和利潤率趨勢
• 市場滲透率
• 消費者分析
• 法規概述

第7章 競爭訊息

• 市場定位
• 市場占有率
• 競爭基準
• 主要企業的策略

第8章 公司簡介

• Phibro Animal Health
• Vetoquinol
• Heska Corporation
• Neogen Corporation
• Dechra Pharmaceuticals
• Virbac
• Zoetis
• Elanco Animal Health
• Boehringer Ingelheim Animal Health
• Ceva Sante Animale
• IDEXX Laboratories
• Bimeda
• Norbrook Laboratories
• Ourofino Saude Animal
• Kyoritsu Seiyaku
• Aratana Therapeutics
• Eco Animal Health
• Kraeber & Co
• Avivagen
• Pet IQ

第9章：關於我們

Animal Health Market is anticipated to expand from $58.5 billion in 2024 to $91.2 billion by 2034, growing at a CAGR of approximately 5.1%. The Animal Health Market encompasses products and services aimed at improving the health and well-being of animals, including pharmaceuticals, vaccines, diagnostics, and feed additives. This sector addresses both companion and livestock animals, focusing on disease prevention, treatment, and management. Rising pet ownership, increasing livestock production, and advancements in veterinary technology are key drivers, fostering innovation in biologics and digital health solutions to enhance animal care and productivity.

The Animal Health Market is experiencing robust growth, primarily driven by advancements in veterinary pharmaceuticals and diagnostics. The pharmaceuticals segment leads the market, with parasiticides and anti-infectives emerging as top-performing sub-segments due to increasing pet ownership and livestock health awareness. Vaccines follow closely, propelled by the rising demand for preventive care in animals. The diagnostics segment is gaining momentum, with molecular diagnostics and immunodiagnostics being the second highest performing sub-segments. These technologies offer precision in disease detection, enhancing treatment outcomes. Companion animal diagnostics are particularly in demand, reflecting the growing bond between humans and pets. The feed additives segment, focusing on nutritional supplements and growth enhancers, is also expanding. This growth is attributed to the need for improved animal productivity and health. The market is further supported by innovations in digital animal health solutions, which streamline veterinary practices and enhance animal care efficiency.

The Animal Health Market is characterized by a diverse market share, with established companies and emerging players introducing innovative solutions. Pricing strategies reflect a balance between premium products and cost-effective alternatives, catering to varied consumer needs. Recent product launches highlight advancements in pharmaceuticals and diagnostic tools, emphasizing enhanced efficacy and user convenience. This dynamic landscape is shaped by increasing demand for preventive care and the growing pet ownership trend. Competitive benchmarking reveals a concentrated market with a few dominant players, yet new entrants are gaining traction through niche offerings. Regulatory influences are pivotal, with stringent guidelines in regions like North America and Europe dictating market operations. The Asia-Pacific region exhibits significant potential due to favorable regulatory frameworks and increasing animal health awareness. Market analysis indicates a robust CAGR, driven by technological integration and rising investment in veterinary services. Challenges such as regulatory compliance and market saturation persist, yet innovation in biopharmaceuticals and digital health solutions presents substantial growth opportunities.

Geographical Overview:

The animal health market is witnessing robust growth across various regions, with each presenting unique opportunities. North America leads the market, driven by advanced veterinary healthcare infrastructure and increased pet ownership. The region's focus on preventative care and innovative treatments enhances its market position. Europe follows, with strong demand for livestock health products due to stringent regulatory standards and a focus on food safety. The region also benefits from a growing awareness of animal welfare. In Asia Pacific, rapid urbanization and rising disposable incomes are fueling market expansion. Countries like China and India are emerging as key growth pockets, with increasing investments in veterinary services and pharmaceuticals. Latin America and the Middle East & Africa are gaining traction, with a growing emphasis on livestock health to support agricultural productivity. Brazil and South Africa are notable emerging markets, recognizing the importance of animal health in economic development and food security.

The global animal health market is navigating a complex web of tariffs, geopolitical tensions, and evolving supply chain dynamics. In Japan and South Korea, strategies are increasingly focused on enhancing domestic production capabilities to mitigate tariff impacts and reduce reliance on imports. China is accelerating its investment in biotech innovation to counteract export restrictions and bolster self-sufficiency. Taiwan, while pivotal in biotechnology, faces geopolitical vulnerabilities due to its position in US-China trade disputes. The parent market is experiencing robust growth, driven by rising pet ownership and livestock health investments. By 2035, the market is poised for expansion, contingent on resilient supply chains and strategic partnerships. Additionally, conflicts in the Middle East may indirectly influence global supply chains and energy prices, impacting production costs and market stability.

Key Trends and Drivers:

The animal health market is experiencing robust growth, driven by increased pet ownership and heightened awareness of animal welfare. Key trends include the rise in preventive healthcare and wellness products for pets, reflecting a shift towards proactive animal care. Advances in veterinary diagnostics and therapeutics are enabling early disease detection and effective treatment, enhancing overall animal health outcomes. Another significant driver is the growing demand for livestock products, which necessitates improved animal husbandry practices and disease management. The integration of digital technologies, such as telemedicine and wearable devices, is revolutionizing animal healthcare by providing real-time monitoring and remote consultations. These innovations are particularly beneficial in rural and underserved areas. Additionally, regulatory support and government initiatives aimed at ensuring food safety and zoonotic disease control are bolstering market growth. Opportunities abound in emerging markets where the livestock industry is expanding rapidly. Companies that can offer cost-effective and innovative solutions are well-positioned to capitalize on these trends, ensuring sustainable growth in the animal health sector.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by End User
• 2.7 Key Market Highlights by Device
• 2.8 Key Market Highlights by Process
• 2.9 Key Market Highlights by Solutions

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Pharmaceuticals
  • 4.1.2 Biologics
  • 4.1.3 Feed Additives
  • 4.1.4 Vaccines
  • 4.1.5 Diagnostics
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Anti-Infectives
  • 4.2.2 Parasiticides
  • 4.2.3 Anti-Inflammatories
  • 4.2.4 Medicinal Feed Additives
  • 4.2.5 Nutritional Feed Additives
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Veterinary Clinics
  • 4.3.2 Mobile Veterinary Services
  • 4.3.3 Telemedicine
  • 4.3.4 Animal Rehabilitation
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Molecular Diagnostics
  • 4.4.2 Immunodiagnostics
  • 4.4.3 Clinical Biochemistry
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Companion Animals
  • 4.5.2 Livestock
  • 4.5.3 Aquaculture
  • 4.5.4 Avian
• 4.6 Market Size & Forecast by End User (2020-2035)
  • 4.6.1 Veterinary Hospitals
  • 4.6.2 Animal Farms
  • 4.6.3 Research Institutes
• 4.7 Market Size & Forecast by Device (2020-2035)
  • 4.7.1 Surgical Instruments
  • 4.7.2 Imaging Devices
  • 4.7.3 Monitoring Devices
• 4.8 Market Size & Forecast by Process (2020-2035)
  • 4.8.1 Drug Development
  • 4.8.2 Vaccine Production
  • 4.8.3 Feed Manufacturing
• 4.9 Market Size & Forecast by Solutions (2020-2035)
  • 4.9.1 Disease Management
  • 4.9.2 Herd Management

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Application
    • 5.2.1.6 End User
    • 5.2.1.7 Device
    • 5.2.1.8 Process
    • 5.2.1.9 Solutions
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Application
    • 5.2.2.6 End User
    • 5.2.2.7 Device
    • 5.2.2.8 Process
    • 5.2.2.9 Solutions
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Application
    • 5.2.3.6 End User
    • 5.2.3.7 Device
    • 5.2.3.8 Process
    • 5.2.3.9 Solutions
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Application
    • 5.3.1.6 End User
    • 5.3.1.7 Device
    • 5.3.1.8 Process
    • 5.3.1.9 Solutions
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Application
    • 5.3.2.6 End User
    • 5.3.2.7 Device
    • 5.3.2.8 Process
    • 5.3.2.9 Solutions
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Application
    • 5.3.3.6 End User
    • 5.3.3.7 Device
    • 5.3.3.8 Process
    • 5.3.3.9 Solutions
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Application
    • 5.4.1.6 End User
    • 5.4.1.7 Device
    • 5.4.1.8 Process
    • 5.4.1.9 Solutions
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Application
    • 5.4.2.6 End User
    • 5.4.2.7 Device
    • 5.4.2.8 Process
    • 5.4.2.9 Solutions
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Application
    • 5.4.3.6 End User
    • 5.4.3.7 Device
    • 5.4.3.8 Process
    • 5.4.3.9 Solutions
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Application
    • 5.4.4.6 End User
    • 5.4.4.7 Device
    • 5.4.4.8 Process
    • 5.4.4.9 Solutions
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Application
    • 5.4.5.6 End User
    • 5.4.5.7 Device
    • 5.4.5.8 Process
    • 5.4.5.9 Solutions
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Application
    • 5.4.6.6 End User
    • 5.4.6.7 Device
    • 5.4.6.8 Process
    • 5.4.6.9 Solutions
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Application
    • 5.4.7.6 End User
    • 5.4.7.7 Device
    • 5.4.7.8 Process
    • 5.4.7.9 Solutions
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Application
    • 5.5.1.6 End User
    • 5.5.1.7 Device
    • 5.5.1.8 Process
    • 5.5.1.9 Solutions
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Application
    • 5.5.2.6 End User
    • 5.5.2.7 Device
    • 5.5.2.8 Process
    • 5.5.2.9 Solutions
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Application
    • 5.5.3.6 End User
    • 5.5.3.7 Device
    • 5.5.3.8 Process
    • 5.5.3.9 Solutions
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Application
    • 5.5.4.6 End User
    • 5.5.4.7 Device
    • 5.5.4.8 Process
    • 5.5.4.9 Solutions
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Application
    • 5.5.5.6 End User
    • 5.5.5.7 Device
    • 5.5.5.8 Process
    • 5.5.5.9 Solutions
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Application
    • 5.5.6.6 End User
    • 5.5.6.7 Device
    • 5.5.6.8 Process
    • 5.5.6.9 Solutions
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Application
    • 5.6.1.6 End User
    • 5.6.1.7 Device
    • 5.6.1.8 Process
    • 5.6.1.9 Solutions
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Application
    • 5.6.2.6 End User
    • 5.6.2.7 Device
    • 5.6.2.8 Process
    • 5.6.2.9 Solutions
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Application
    • 5.6.3.6 End User
    • 5.6.3.7 Device
    • 5.6.3.8 Process
    • 5.6.3.9 Solutions
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Application
    • 5.6.4.6 End User
    • 5.6.4.7 Device
    • 5.6.4.8 Process
    • 5.6.4.9 Solutions
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Application
    • 5.6.5.6 End User
    • 5.6.5.7 Device
    • 5.6.5.8 Process
    • 5.6.5.9 Solutions

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Phibro Animal Health
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Vetoquinol
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Heska Corporation
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Neogen Corporation
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Dechra Pharmaceuticals
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Virbac
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Zoetis
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Elanco Animal Health
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Boehringer Ingelheim Animal Health
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Ceva Sante Animale
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 IDEXX Laboratories
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Bimeda
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Norbrook Laboratories
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Ourofino Saude Animal
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Kyoritsu Seiyaku
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Aratana Therapeutics
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Eco Animal Health
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Kraeber & Co
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Avivagen
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Pet IQ
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us